M&A Deal Summary

BioDerm Acquires Argentum

On February 7, 2023, BioDerm acquired medical products company Argentum from Shore Capital Partners

Acquisition Highlights
  • This is BioDerm’s 1st transaction in the Medical Products sector.
  • This is BioDerm’s 1st transaction in the United States.
  • This is BioDerm’s 1st transaction in Illinois.

M&A Deal Summary
Date 2023-02-07
Target Argentum
Sector Medical Products
Buyer(s) BioDerm
Sellers(s) Shore Capital Partners
Deal Type Add-on Acquisition

Target

Argentum

Geneva, Illinois, United States
Argentum is a manufacturer and sells innovative wound care products across a wide number of clinical applications, including the Silverlon® (“Silverlon”) brand, its rapidly-growing, proprietary range of silver-based antimicrobial products. The core platform technology in Silverlon is a uniquely designed silver-plated nylon matrix that provides the powerful antimicrobial properties of silver ions in the dressing without staining the skin and without increasing bioburden. Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, burns, chronic wounds, IV catheter-related wounds, and for negative pressure wound therapy. Argentum was founded in 2001 and is based in Geneva, Illinois.

Search 197,704 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BioDerm

Largo, Florida, United States
Category Company
Founded 1991
Sector Medical Products
DESCRIPTION

BioDerm is a manufacturer of proprietary hydrocolloid products for urinary management, securement, infection control, and skin protection. BioDerm also provides custom wound care daily dressing change kits to patients with ventricular assist devices installed due to heart failure. BioDerm was founded in 1991 and is based in Largo, Florida.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Illinois) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1

Seller(S) 1

SELLER

Shore Capital Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2009
PE ASSETS 350M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Shore Capital Partners is a private equity group focused on opportunities in healthcare, food/beverages, and business services. Specific healthcare areas of interest include infusion therapy, laboratory services, laboratory products/distribution, outpatient rehab therapy, and behavioral health. Shore looks to invest in proven businesses with stable cash-flows and 'significant' growth potential. Prospective companies typically have $5 to $50 million in sales and $1 to $7 million of EBITDA. Shore Capital was formed in 2009 and is based in Chicago, Illinois.

DEAL STATS #
Overall 9 of 12
Sector (Medical Products) 3 of 4
Type (Add-on Acquisition) 5 of 5
State (Illinois) 1 of 2
Country (United States) 9 of 12
Year (2023) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-03 IZI Medical

Owings Mills, Maryland, United States

IZI Medical is a developer, manufacturer, and provider of medical consumable accessories used in radiology, radiation therapy, vertebroplasty, and image-guided surgery procedures. IZI has built a diverse portfolio of products backed by strong intellectual property and currently sells to more than 1,000 domestic customers as well as internationally across 25 countries. IZI Medical was formed in 1991 and is based in Owings Mills, Maryland.

Sell £138M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-13 CSI

Hillsboro, Kansas, United States

CSI is a manufacturer of rigid plastic packaging services, specializing in the production of PET containers and HDPE containers for specialty food & beverage and other manufacturers. CSI was founded in 1991 and is based in Hillsboro, Kansas.

Buy -
Mergr

Product

Company

Legal